Session Details

[LS02]CBC Co., Ltd.

Thu. Mar 27, 2025 12:00 PM - 1:00 PM JST
Thu. Mar 27, 2025 3:00 AM - 4:00 AM UTC
Room 10 (Fukuoka International Congress Center: 412 [4F])
Chair: Noriyasu Kataoka (CBC Co., Ltd.)

[LS02]Innovative technology CESS utilizes supercritical CO2 to significantly enhance the solubility and bioavailability of poorly soluble drugs

○Shigeharu Yokohama1, Jamie Unwin2, Tamas Solymosi2 (1. CBC, 2. Nanoform)